ERBB2 and breast carcinoma: Interestingly, CREB is associated with tumor progression, therapeutic resistance, and patient prognosis32,33, and previous studies have shown that CREB activation contributes to HER2-mediated neoplastic cell growth34 and ROR1-mediated breast cancer cell growth33.